These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Nesto RW Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Ayyobi AF; Brunzell JD Am J Cardiol; 2003 Aug; 92(4A):27J-33J. PubMed ID: 12957324 [TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and risk of stroke. Brown WV Clin Cornerstone; 2004; 6 Suppl 3():S30-4. PubMed ID: 15707267 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome: is it a syndrome? Does it matter? Kahn R Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171 [No Abstract] [Full Text] [Related]
11. [Statin treatment in type 2 diabetes. Is it a must today?]. Faust M MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527 [No Abstract] [Full Text] [Related]
12. Should the insulin resistance syndrome be treated in the elderly? Grant RW; Meigs JB Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733 [TBL] [Abstract][Full Text] [Related]
14. The role of treatment to increase HDL-cholesterol and decrease triglyceride concentrations in prevention of coronary heart disease in Type 2 diabetes. Wild S; Byrne CD Diabet Med; 2004 Sep; 21 Suppl 4():8-11. PubMed ID: 15315518 [No Abstract] [Full Text] [Related]
15. Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome. Sowers JR Am J Cardiol; 2003 Feb; 91(4A):14B-22B. PubMed ID: 12615294 [TBL] [Abstract][Full Text] [Related]
17. Nicotinic acid and HDL-C reduction. S Afr Med J; 2005 Feb; 95(2):89. PubMed ID: 15751197 [No Abstract] [Full Text] [Related]
18. On the road to better dyslipidemia outcomes. Hughes S Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874 [No Abstract] [Full Text] [Related]
19. Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel. Shepherd J; Betteridge J; Van Gaal L; Curr Med Res Opin; 2005 May; 21(5):665-82. PubMed ID: 15969866 [TBL] [Abstract][Full Text] [Related]
20. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]